is metformin a glp-1 receptor GLP1 Agonists—Effects beyond Obesity and Diabetes New aspects of an old

Register for our upcoming webinar, Expanding Access to Obesity Care , for a practical discussion on evolving benefit strategies and sustainable approaches employers can use today

doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

Technical Catalyst Driving the Rally The markets strong reaction is due to three important concerns that the approval immediately addresses

FDA approval ensures that the medications have been thoroughly tested, but ongoing research continues to monitor their long-term effects

Chronic weight management: GLP-1s have gained recent popularity for their use in chronic weight management

He also thinks coverage is the right investment economically, estimating that the North Carolina Medicaid program spends about a billion dollars a year on obesity-related expenses